Prophylactic tranexamic acid appears to be safe and is associated with reduced bleeding in general surgery. However, its ...
ORLADEYO is now the first and only targeted oral prophylactic therapy for patients with HAE aged 2 and above. A capsule ...
ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides ...
Iodine prophylaxis is one of the most frequently searched topics during periods of heightened geopolitical tension, nuclear ...
We explore the disconnect between mycological cure and cosmetic recovery in Tinea Versicolor, focusing on managing patient ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Pfizer disclosed a patient death in a marstacimab hemophilia study, triggering a safety review and reassessment of surgical ...
Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...
A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...
CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...
Long-term follow-up of Taiwanese children with chronic hepatitis B virus (HBV) infection showed that 3.29% had HBV surface ...
Real-world data comparing two negative-pressure wound therapy devices suggests lower pressure may drive better outcomes. Around seven million orthopedic surgeries take place in the U.S. every year1, ...